Comparable Outcomes in Nonsecretory and Secretory Multiple Myeloma after Autologous Stem Cell Transplantation
✍ Scribed by Shaji Kumar; Waleska S. Pérez; Mei-Jie Zhang; Karen Ballen; Asad Bashey; L. Bik To; Christopher N. Bredeson; Mitchell S. Cairo; Gerald J. Elfenbein; César O. Freytes; Robert Peter Gale; John Gibson; Robert A. Kyle; Martha Q. Lacy; Hillard M. Lazarus; Philip L. McCarthy; Gustavo A. Milone; Jan S. Moreb; Santiago Pavlovsky; Donna E. Reece; David H. Vesole; Peter H. Wiernik; Parameswaran Hari
- Book ID
- 116280421
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 214 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1083-8791
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Multiple myeloma (MM) is the most common indication for high‐dose chemotherapy with autologous stem cell transplantation (ASCT) in the U.S. and can be associated with substantial morbidity. Thorough assessment and understanding of symptoms and risk factors for symptom dev